600511 国药股份
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(1,029,845)2,726,6572,395,1231,957,4511,301,671
投资活动产生之现金流量净额(141,499)(129,311)(152,319)(122,991)(56,465)
筹资活动产生之现金流量净额(1,470,917)(632,176)(639,573)(745,962)(730,612)
汇率变动对现金及现金等价物的影响--------(19)
现金及现金等价物净增加/(减少)(2,642,261)1,965,1701,603,2321,088,497514,574
期初现金及现金等价物余额10,798,3188,833,1487,229,9166,141,4195,626,845
期末现金及现金等价物余额8,156,05810,798,3188,833,1487,229,9166,141,419